Status:
TERMINATED
Safety Study of Galantamine in Tic Disorders
Lead Sponsor:
Parkinson's Disease and Movement Disorders Center
Collaborating Sponsors:
Ortho-McNeil Neurologics, Inc.
Conditions:
Tourette's Syndrome
Motor Tic Disorder
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the safety, tolerability and efficacy of galantamine in tic disorders. The impact of galantamine on commonly associated behaviors (i.e. attention, obsessions,...
Detailed Description
Modulation of cholinergic activity is a growing focus in neurologic therapeutics especially for dementing disorders such as Alzheimer disease. Treatment with the recently developed cholinesterase inhi...
Eligibility Criteria
Inclusion
- DSM IV criteria for the diagnosis of Tourette's syndrome, chronic motor or chronic vocal tic disorder
- Accepted method of birth control
Exclusion
- Preganancy or nursing
- Unstable medical illness
- Unstable psychiatric illness
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00226824
Start Date
September 1 2005
End Date
May 1 2007
Last Update
August 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Parkinson's Disease and Movement Disorders Center of Albany Medical Center
Albany, New York, United States, 12205